US, UK issue Obesity Data Challenge

A new data challenge is underway with $40,000 in prizes available for data visualization tools focused on obesity.

In January 2014, the U.S. Department of Health and Human Services (HHS) and the Secretary of State for Health, the National Health Services (NHS) England and the Health & Social Care Information Centre signed a memorandum of understanding, committing to a joint program of work around data and technology. In June 2014, a common theme of obesity was identified for the collaboration.

The Obesity Data Challenge is part of two parallel, prize-based competitions running in the United States and in England, where it is led by the NHS and their organizing partner, Rewired State. Each country’s challenge participants can utilize and mash up open data to develop new data visualization tools to give communities, local health officials, patients and practitioners new means to improve population health, according to an announcement.

In the U.S. portion of the challenge, HHS, the Health Data Consortium and the de Beaumont Foundation are seeking solutions that enable public health and healthcare professionals to help patients and families address the obesity epidemic at a personal and community level.

Submissions will be accepted until July 31 with the winners announced on Aug. 21. Learn more about the Obesity Data Challenge.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.